Home › NDC Lookup › RxCUI directory › RxCUI 1806890

Lisinopril 1 MG/ML Oral Solution [Qbrelis] — RxCUI 1806890

RxNorm drug concept · Semantic branded drug
RxCUI 1806890 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1806890
Official nameLisinopril 1 MG/ML Oral Solution [Qbrelis]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asQbrelis 1 MG/ML Oral Solution; Qbrelis 1 MG in 1 mL Oral Solution; Qbrelis 1 MG per 1 ML Oral Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)8,304 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lisinopril: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Lisinopril is mainly prescribed to treat high blood pressure — it relaxes your blood vessels so your heart doesn't have to work as hard. It's also used to help manage heart failure...
  • Good news — food doesn't affect how lisinopril works, so you can take it with or without a meal. What matters most is taking it at roughly the same time each day. Once a day is the...
  • Can I take lisinopril with food, or does it have to be on an empty stomach?
  • Yes, that cough is one of the most well-known side effects of ACE inhibitors like lisinopril. It happens because the medicine also affects a chemical in the lungs called bradykinin...
📖 Read our full Lisinopril guide →

🕸️ Concept Web — How Lisinopril 1 MG/ML Oral Solution [Qbrelis] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lisinopril 1 MG/ML Oral Solution [Qbrelis] RxCUI 1806890

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lisinopril 29046
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Qbrelis 1806885
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lisinopril Oral Solution 1806883
    • Lisinopril Oral Liquid Product 1806882
    • Lisinopril Oral Product 1164689
    • Lisinopril Oral Solution [Qbrelis] 1806887
    • Qbrelis Oral Liquid Product 1806888
    • Qbrelis Oral Product 1806889
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lisinopril 1 MG/ML Oral Solution SCD · 1806884
  • Lisinopril 1 MG/ML SCDC · 1806881
  • Lisinopril Oral Solution SCDF · 1806883
  • Lisinopril Oral Liquid Product SCDG · 1806882
  • Lisinopril Oral Product SCDG · 1164689

Brand-Name Concepts

  • Lisinopril 1 MG/ML [Qbrelis] SBDC · 1806886
  • Lisinopril Oral Solution [Qbrelis] SBDF · 1806887
  • Qbrelis Oral Liquid Product SBDG · 1806888
  • Qbrelis Oral Product SBDG · 1806889
  • Qbrelis BN · 1806885

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1806890 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
52652-3001-01 150 mL in 1 BOTTLE (52652-3001-1) Qbrelis Azurity Pharmaceuticals, Inc. 2016-08-29
Observed labelers: Azurity Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$4.4804
Range $4.4804–$4.4804 · middle 50% $4.4804–$4.4804 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.